GMP Manufacturing Facility

PharmaCore® has developed an outstanding state-of-the-art facility to serve the growing need for GMP clinical material and bulk active pharmaceutical ingredients (APIs) accompanying the rapid pace of drug discovery.

The PharmaCore® GMP manufacturing facility includes:

• Five new process suites
• Broad process capability
• GMP analytical testing
• Stability chambers and testing
• Sample retention
• Process safety testing
• GMP regulatory support

The new 16,000 square foot facility will allow PharmaCore® to deliver GMP projects ranging in scale from mgs to approximately 100kg.

PharmaCore®’s specially trained, GMP manufacturing team operates under the USFDA Guidelines for Bulk Pharmaceutical Chemicals (BPC), www.fda.gov, and is backed by a comprehensive documentation system.

Customers are invited to discuss GMP projects and audit the PharmaCore® facilities.